ReviewCurrent drug research reviews2024

Liraglutide Improves Diabetic Cardiomyopathy by Downregulation of Cardiac Inflammatory and Apoptosis Markers.

Polly Gupta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.